Key result
POTS linked to enhanced GIP secretion and exacerbated orthostatic tachycardia after oral glucose.
Why the study?
Postural tachycardia syndrome symptoms are exacerbated after consuming a high-carbohydrate meal, but the precise underlying mechanism remains unknown.
Does glucose intake worsen orthostatic tachycardia and alter gastrointestinal hormone secretion in women with POTS?
Case-Control (n=25)
No
Does glucose intake worsen orthostatic tachycardia and alter gastrointestinal hormone secretion in women with POTS?
Glucose-induced worsening of orthostatic tachycardia in POTS is associated with a decline in stroke volume and elevated levels of the splanchnic vasodilator GIP.
Answers are grounded in this paper and cite their sources.
Glucose may exacerbate orthostatic tachycardia in POTS via GIP; hypothesis-generating for mechanistic and interventional studies.
Background: Postural tachycardia syndrome (POTS) is characterized by excessive upright tachycardia and disabling presyncopal symptoms, which are exacerbated after consuming a high-carbohydrate meal; it is unknown, however, what is the precise underlying mechanism. We seek to investigate the effect of glucose intake on orthostatic hemodynamic changes and gastrointestinal hormone secretion in POTS. Methods: Prospective, case-control study, 12 women with POTS who reported a postprandial worsening of their POTS symptoms and 13 age-matched female controls received 75-g oral glucose and 20 mg/kg acetaminophen to assess nutrient absorption. Hemodynamic, gastrointestinal hormone and acetaminophen levels were measured for up to 120 minutes postingestion while supine and standing. Results: Patients with POTS had significant orthostatic tachycardia, 48.7±11.2 versus 23.3±8.1 bpm, P =0.012 and elevated upright norepinephrine levels, 835.2±368.4 versus 356.9±156.7 pg/mL, P =0.004. After oral glucose, upright heart rate significantly increased in POTS, 21.2±11.9% versus 6.0±19.9%, P =0.033 with a concomitant decline in upright stroke volume, −10.3±11.90% versus 3.3±13.7%, P =0.027; total peripheral resistance, blood pressure and cardiac output remained unaltered. Acetaminophen rate of appearance was similar between groups ( P =0.707), indicating comparable nutrient absorption rates. POTS had increased plasma levels of C-peptide ( P =0.001), GIP (glucose-dependent insulinotropic polypeptide; P =0.001), peptide YY ( P =0.016), and pancreatic polypeptide ( P =0.04) following glucose consumption, but only GIP had a time-dependent association with the worsening upright tachycardia and stroke volume fall. Conclusions: The glucose-induced worsening orthostatic tachycardia in POTS was associated with a decline in SV; these changes occurred while GIP, a splanchnic vasodilator, was maximally elevated.
No takes yet. Share an insight, caveat, or question.
Breier et al. (2022) conducted a case-control in Postural Tachycardia Syndrome (POTS) (n=25). Postural Tachycardia Syndrome (POTS) vs. Age-matched healthy controls was evaluated on Plasma glucose-dependent insulinotropic polypeptide (GIP) levels following oral glucose consumption (p=0.001). Postural Tachycardia Syndrome was associated with significantly enhanced secretion of the splanchnic vasodilator GIP (P=0.001) and worsening orthostatic tachycardia after oral glucose compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: